After the merger, AAH was expected to have $167mil in cash and 235mil shares on issue, so that's cash value of $0.71
Add to that the $17.7mil recently received, less running costs since the merger, add the $100+mil expected in from the current patents until they expire in 2010... gives a cash value (before discounting and other running costs) of around $1.20.
So it's pretty much trading below cash value right now!
- Forums
- ASX - By Stock
- AAH
- another 17.7 million
AAH
arana therapeutics limited
another 17.7 million, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla